Stryker (SYK) Tops Q4 EPS by 8c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts SYK Hot Sheet
Price: $303.13 -1.58%
Revenue Growth %: +10.4%
Financial Fact:
Total operating expenses: 1.39B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +10.4%
Financial Fact:
Total operating expenses: 1.39B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Stryker (NYSE: SYK) reported Q4 EPS of $4.47, $0.08 better than the analyst estimate of $4.39. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $7.12 billion.
GUIDANCE:
Stryker sees FY2026 EPS of $14.90-$15.10.
For earnings history and earnings-related data on Stryker (SYK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
